Selected References:
- DeSisto CL, et al. 2021. Risk of stillbirth among women with and without COVID-19 at delivery hospitalization – United States, March 2020 – September 2021. https://www.cdc.gov/mmwr/volumes/70/wr/mm7047e1.htm?s_cid=mm7047e1_w
- Kasehagen L, et al. 2021. COVID-19 – associated deaths after SARS-CoV-2 infection during pregnancy – Mississippi, March 1, 2020 – October 6, 2021.
- Food and Drug Administration. 2021. Fact Sheet for Healthcare Providers: Emergency Use Authorization for Molnupiravir. https://www.fda.gov/media/155054/download
- Merck & Co. Center for Drug Evaluation and Research Antimicrobial Drugs Advisory Committee Meeting Briefing Document. 2021. Molnupiravir. https://www.fda.gov/media/154421/download
- 2021. Molnupiravir. https://www.fda.gov/media/154472/download
- Regan AK, et al. 2021. SARS-CoV-2 infection during pregnancy and associated perinatal health outcomes: a national US cohort study. J Infect Dis Dec 27; jiab626. doi: 10.1093/infdis/jiab626.
